Neuro Endocrinol Lett. 2006 Aug 5;27(4) [Epub ahead of print]

Mercury toxicity presenting as Chronic Fatigue, memory impairment and depression: Diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994-2006).

Wojcik DP, Godfrey ME, Christie D, Haley BE. Northland Environmental Health Clinic, 2 Dip Rd, Kamo, Whangarei, Northland, New Zealand. wojcik@wave.co.nz.

In a group of 465 patients diagnosed as having chronic mercury toxicity (CMT), 32.3% had severe fatigue, 88.8% had memory loss, and 27.5% had depression. A significant correlation was found between CMT and the Apo-lipoprotein E4 genotype (p=0.001). An investigation into an additional 864 consecutively seen general practice patients, resulted in 30.3% having evidence consistent with CMT, and once again a significant correlation was found with the APO-E4 genotype (p=0.001). Removal of amalgam mercury fillings when combined with appropriate treatment resulted in a significant symptom reduction (p< 0.001) to levels reported by healthy subjects.

PMID: 16891999 [PubMed - as supplied by publisher]

Comments (0)

Subscribe to this comment's feed

Show/hide comments

Show/hide comment form

Name

Email

Comment

smaller | bigger

Subscribe via email (registered users only)

I have read and agree to the Terms of Usage.

Add Comment